Efficacy and Safety of Admilparant, an LPA1 Antagonist, in Pulmonary Fibrosis: A Phase 2 Randomized Clinical Trial
1. 系统已在2025-10-03 16:39:58对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1164/rccm.202405-0977OC
文献链接: https://www.atsjournals.org/doi/10.1164/rccm.202405-0977OC
其他信息:
出版社: American Thoracic Society
作者: Tamera J. Corte; Juergen Behr; Vincent Cottin; Marilyn K. Glassberg; Michael Kreuter; Fernando J. Martinez; Takashi Ogura; Takafumi Suda; Marlies Wijsenbeek; Elchonon Berkowitz; Brandon Elpers; Sinae Kim; Hideaki Watanabe; Aryeh Fischer; Toby M. Maher